Interleukin-12 and protective immunity to schistosomes

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 1, 1998, Pages 163-169

  Mountford, A P ^a   Shires, V L ^a   Anderson, S ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Adjuvant; Interleukin 12; Schistosoma; Th1; Vaccine

Indexed keywords

CYTOKINE ANTIBODY; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; PARASITE ANTIGEN; SCHISTOSOMA VACCINE;

CELLULAR IMMUNITY; GENE DISRUPTION; LYMPH NODE; NATURAL KILLER CELL; NONHUMAN; REVIEW; SCHISTOSOMA MANSONI; VACCINATION;

SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 0031889670     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000100023     Document Type: Review

References (24)

1. Wolf SF, Sieburth D & Sypeck J (1994). Interleukin 12: A key modulator of immune function. Stem Cells, 12: 154-168.
2. Trinchieri G (1995). Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annual Review of Immunology, 13: 251-276.
3. Sypeck JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF & Schaub FG (1993). Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response. Journal of Experimental Medicine, 177: 1797-1802.
4. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE & Gately MK (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. Journal of Experimental Medicine, 177: 1505-1509.
5. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA & Alber G (1996). Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. European Journal of Immunology, 26: 1553-1559.
6. Gazzinelli RT, Hieny S, Wynn TA, Wolf SF & Sher A (1993). Interleukin 12 is required for the T-lymphocyte-independent induction of Interferon γby an intracellular parasite and induces resistance in T-cell-deficient hosts. Proceedings of the National Academy of Sciences, USA, 90: 6115-6119.
7. Finkelman FD, Madden KB, Cheever AW, Katona IM, Morris SC, Gately MK, Hubbard BR, Gause WC & Urban JF (1994). Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. Journal of Experimental Medicine, 179: 1563-1572.
8. Pearlman E, Heinzel FP, Hazlett Jr FE & Kazura JW (1995). IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. Journal of Immunology, 154: 4658-4664.
9. Wynn TA, Cheever AW, Jankovic D., Poindexter RW, Caspar P, Lewis FA & Sher A (1995). An IL-12 based vaccination method for preventing fibrosis induced by schistosome infection. Nature, 376: 594-596.
10. Pearce EJ, Caspar P, Gryzch J-M, Lewis FA & Sher A (1991). Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. Journal of Experimental Medicine, 173: 159-166.
11. Wilson RA (1990). Leaky livers, portal shunting and immunity to schistosomes. Parasitology Today, 6: 354-358.
12. Mountford AP, Coulson PS, Pemberton RM, Smythies LE & Wilson RA (1992). The generation of interferon-gamma-secreting T lymphocytes in the skin-draining lymph nodes and their recruitment to the lungs is associated with protective immunity to Schistosoma mansoni. Immunology, 75: 250-256.
13. Smythies LE, Pemberton RM, Coulson PS, Mountford AP & Wilson RA (1992). T cell-derived cytokines associated with pulmonary immune mechanisms in mice vaccinated with irradiated cercariae of Schistosoma mansoni. Journal of Immunology, 148: 1512-1518.
14. Smythies LE, Betts C, Coulson PS, Dowling M-A & Wilson RA (1996). Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosoma mansoni. Parasite Immunology, 18: 359-369.
15. Smythies LE, Coulson PS & Wilson RA (1992). Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice previously vaccinated with attenuated cercariae. Journal of Immunology, 149: 3654-3658.
16. Wilson RA, Coulson PS, Betts C, Dowling M-A & Smythies LE (1996). Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-γ receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology, 87: 275-282.
17. Betts CJ (1996). RT-PCR analysis of cytokine expression in murine lymph node and lung tissue following exposure to the irradiated Schistosoma mansoni vaccine. Doctoral thesis, The University of York, York, UK.
18. Wynn TA, Jankovic D, Hieny S, Cheever AW & Sher A (1995). IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. Journal of Immunology, 154: 4701-4709.
19. Coulson PS & Mountford AP (1989). Fate of attenuated schistosomula administered by different routes, relative to the immunity induced against Schistosoma mansoni. Parasitology, 99: 39-45.
20. Harrop R & Wilson RA (1993). Protein synthesis and release by cultured schistosomula of Schistosoma mansoni. Parasitology, 107: 265-274.
21. Mountford AP, Harrop R & Wilson RA (1995). Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma Interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Infection and Immunity, 63: 1980-1986.
22. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukada S & Kurimoto M (1995). Cloning of a new cytokine that induces IFNγ production by T-cells. Nature, 378: 88-89.
23. Mountford AP, Anderson S & Wilson RA (1996). Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. Journal of Immunology. 156: 4739-4745.
24. Wynn TA, Jankovic D, Hieny S, Zioncheck K, Jardieu P. Cheever AW & Sher A (1995). IL-12 exacerbates rather than suppresses Th2-dependent pathology in the absence of endogenous IFNγ. Journal of Immunology, 154: 3999-4009.